Found 4 matching trials
Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma
PHASE1Background:
* Hodgkins lymphoma (HL) is a highly treatable cancer. However...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Monoclonal Antibody Therapy in Treating Patients With Leukemia
PHASE1RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia
PHASE1This study will examine the use of a radioactive monoclonal antibody called...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac
PHASE1The study purpose is to evaluate the clinical response to multidose adminis...
Location
National Cancer Institute (NCI)